semaj83/ctmatch_classification huggingface dataset:
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 25.0-64.0,  Cervical Cancer Uterine Cervical Neoplasms Human Papillomavirus Female Aged 25 to 64 years old Living at ≤250% of the federal poverty line Eligible to receive cervical cancer screening from a study-associated clinic Resides within the same or bordering county of a study-associated clinic  Completion of cervical Pap screening in preceding 4 years Completion of HPV testing in preceding 6 years Pregnant History of hysterectomy Private insurance Unable to provide informed consent
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervix Cancer Histologic confirmed invasive cervical cancer Diagnosis of FIGO stages Stage 1B to 2A high risk -4B or recurrent disease Patients ≥18 years old  Non-invasive uterine carcinoma; 2. Pregnancy; 3. synchronous tumor or second primary tumor in the past 5 years (except thyreoid ancer or non-melanoma skin cancer)
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-40.0,  Endometriosis Women in reproductive age group scheduled for laparoscopy for any indication  Women subject to any hormonal therapy in the last 3 months Women with chronic endocrine disease like diabetes mellitus Women diagnosed with pelvic inflammatory disease (PID) Severe medical disorder that prohibits the laparoscopic procedure, such as cardiovascular disease and pulmonary disease
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Cancer Women 18 years and older Women with documented HIV-infection in their medical record or by on-site testing through voluntary counseling and testing Women willing to undergo pelvic examination and cervical cancer screening Women willing to provide written, informed consent  Pregnancy
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 30.0-49.0,  Cervical Precancer 49 years HPV-positive Attending the cervical cancer screening program conducted by the Saint-Damien Health-Care Centre Understands study procedures and accepts voluntarily to participate by signing the informed consent form (ICF)  Previous Hysterectomy Conditions that can interfere with visualization of the cervix Pregnancy > 20 weeks Not able to comply with protocol study
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 25.0-69.0,  Cancer of the Uterine Cervix No previous cervical cancer screening test in the last three years  pregnancy previous hysterectomy
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cancer of the Oropharynx Patients older than 18 years of age with histologically proven squamous cell carcinoma of the oropharynx HPV-negative disease status by routine p16 immunohistochemical (IHC) staining or in situ hybridization (ISH) of biopsied tumor tissue or >10 pack-year cigarette smoking history Stage T1-4, N0-3 disease, as defined by American Joint Committee on Cancer (AJCC) Eastern Cooperative Oncology Group (ECOG) (Zubrod) Performance Status 0-2  Patients who have undergone resection of primary disease Patients who have received induction chemotherapy for their oropharynx cancer diagnosis Prior cancer diagnosis within 5 years, except appropriately treated localized epithelial skin cancer or cervical cancer Prior radiation therapy to the head and neck region Women of childbearing potential (a woman of child-bearing potential is a sexually mature woman who has not undergone a hysterectomy or who has not been naturally postmenopausal for at least 24 consecutive months [i.e., who has had menses at any time in the preceding 24 months]) and male participants must practice effective contraception (oral, injectable, or implantable hormonal contraceptive; tubal ligation; intra-uterine device; barrier contraceptive with spermicide; or vasectomized partner) throughout the study Patient unable to tolerate MRI or having an estimated Glomerular Filtration Rate (GFR) <60 ml/min/1.73 m2 Severe, active co-morbidity, defined as follows Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months Transmural myocardial infarction within the last 6 months Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 21.0-65.0,  Malignant Neoplasms of Female Genital Organs Women with an abnormal Pap test, positive HPV test or any history of cervical dysplasia 2. Women with an intact cervix (patients who have undergone previous LEEP, cone and/or cryotherapy are eligible) 3. Women of childbearing potential must have a negative urine or serum pregnancy test 4. Women who are at least 21 years of age or older 5. Ability to understand and the willingness to provide informed consent and sign a written Informed Consent Document (ICD) 6. For patients that present to clinic to have a cervical excisional procedure (LEEP) for an already confirmed diagnosis of high grade cervical dysplasia, HRME imaging study will be performed and cervical biopsies might be taken for research purposes only. Since these patients have already the confirmed diagnosis of high-grade cervical dysplasia, any extra biopsies taken will be for research purposes only and our research fund will pay them  Women < 21 years of age 2. Women who have undergone a hysterectomy with removal of the cervix 3. Women with a known allergy to proflavine, acriflavine, or iodine 4. Women who are pregnant or nursing 5. Patients unable or unwilling to provide informed consent or sign a written Informed Consent Document (ICD)
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 30.0-65.0,  Malignant Tumor of Cervix Cervical Intraepithelial Neoplasia To be a woman Aged from 30 to 65 years (30 and 65 years included) Without reimbursement of a pap-test by the health insurance for more than 3 years, despite a reminder mailed by the health insurance on the previous year (list set up by the health insurance) Able to understand and sign voluntarily the consent to participate Warranted by the health insurance Able to understand and answer the questions of the study questionnaire alone or with the help of a self-chosen third party  No vaginal intercourse ever Pap-test quoted on another budget (hospital, mother and child protection…) conducted less than 3 years ago Known cervical lesion or known HPV status History of hysterectomy History of conisation History of laser treatment of the cervix History of cervical cancer Other medical reason to delay cervical cancer screening Abroad for more than one year Moving to another region (done or expected)
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Human Papillomavirus-Related Cervical Carcinoma Histologic proven of cervical intraepithelial neoplasia or carcinoma in situ (CIS) or invasive cervical cancer or a Pap smear on which at least one HPV has been detected Patients not vaccinated against HPV Age >18 years EOCG performance status ≤ 3 Patient must be affiliated to a social security system Ability to provide written informed consent patient's legal capacity to consent to study participation and to understand and comply with the requirements of the study  Patients vaccinated against HPV Pregnant woman over 10 weeks Patient who underwent head and neck radiotherapy dating less than one year Patients deprived of liberty or under supervision
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 30.0-40.0,  Cervix Diseases All cervical screening programme defaulters living in Coventry  Pregnancy 2. Total hysterectomy (abdominal/laparoscopic/vaginal) 3. Never been sexually active/ intimate 4. Women who cannot give valid, informed, written consent 5. HPV self-sample returned without a signed consent form 6. Women who request the research team to be excluded from the trial 7. Women who have written to the Screening Services to record their refusal to take part in the 8. Women who are identified as becoming pregnant or undergoing hysterectomy following the initial test will be excluded from the analysis of data for secondary outcomes
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 14.0-50.0,  Contraception Postpartum Period Pregnant; at least 28 weeks gestation HIV negative Daily access to a mobile phone Planning to stay in area for 6 months postpartum Able to read/write or has trusted person to help  Does not meet above
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-75.0,  Pouchitis Signed informed consent Man or woman between 18 and 70 years of age Ileal Pouch-Anal Anastomosis (IPAA) after colectomy for ulcerative colitis Active pouchitis, defined as a modified pouch disease activity index (mPDAI) ≥ 5 and a history of ≥ 4 antibiotic therapies for pouchitis in the last 12 months or Need for ongoing antibiotic therapy (> 4 weeks) to maintain clinical remission and a history of at least 2 attempts in the last 24 months to stop antibiotic therapy resulting in pouchitis episodes  Treatment with biologics (e.g. infliximab, adalimumab, golimumab, vedolizumab) Treatment with immunomodulators (azathioprine, 6-mercaptopurine (6-MP), methotrexate), steroids or any investigational drugs Use of cholestyramine Crohn's disease of the pouch Known cytomegalovirus infection of the pouch Clostridium difficile infection Isolated cuffitis Clinical significant strictures of the pouch inlet or outlet Concurrent intestinal obstruction History of familial adenomatous polyposis
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 20.0-999.0,  Recurrence Metastasis Death histologically or cytopathologically proven head and neck squamous cell carcinoma Age ≥ 20 years. Measurable or evaluable disease according to Response Evaluation In Solid Tumors(RECIST) criteria. Ability to sign informed consent  Prior cancers within 5 years, except for non-melanoma skin cancers, and in situ cervical cancers. Inability to completely with study and/or follow-up procedures
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervical Cancer years and older Patients previously or newly diagnosed with invasive cervical cancer healthy women without a diagnosis of any type of cancer English speaking Able to provide informed consent, biological and questionnaire data  Pregnant women
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 25.0-65.0,  Cervical HPV-16 and / or HPV-18 Infection Age 25 to 65 years of age with the sex life of female patients HPV DNA typing test for HPV-16 and/ or HPV-18 positive in 1 month  Patients with cervical intraepithelial neoplasia Ⅱ / Ⅲ, cervical cancer Associated with fungal vaginitis, trichomonas vaginitis, HIV positive patients Associated with acute, severe bacterial or viral infection Autoimmune diseases Within 3 months before screening patients used corticosteroids, immunosuppressants or other antiviral drugs Allergies or allergy to the drug known ingredients History of suffering CNS diseases, epilepsy and/or psychological disorder Pregnant and lactating women The researchers do not consider it appropriate clinical trials
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 31.0-65.0,  HPV Infection to live in the Ardennes department (France) affiliation to a health insurance organism to 65 years old  current follow-up for cervical cytological abnormalities history of hysterectomy reimbursement for a Pap smear in the last 3 years
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-65.0,  Papillary Thyroid Carcinoma Newly diagnosed papillary thyroid carcinoma Undergo thyroidectomy according to the China thyroid association guidelines forthe Management of thyroid nodule and thyroid cancer  Current substance abuse/dependence Daily tobacco and alcohol use Whole neck irradiation or surgery Prior cancer diagnosis or chemotherapy treatment Active autoimmune disorder Uncontrolled allergic condition or asthma Chronic use of oral steroid medication Hormone therapy (estrogen, progestin compounds)
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 25.0-65.0,  Cervical Intraepithelial Neoplasia Between 25 and 65 years old Scheduled for a hysterectomy for reasons other than cervical precancer or cancer Diagnosis of uterine, endometrial, ovarian or other cancer that does not jeopardize the tissue of the cervix is permitted Histological evaluation of the cervix does not interfere with the woman's current diagnosis Woman consents to participate after being informed about the study Normal Pap Smear or HPV test in the past 3 years  Pregnancy History of cervical surgery in past 5 years Presence of cervical lesion pre-invasive or invasive on the cervix * Current Pelvic Inflammatory Disorder or severe acute cervicitis Cervix shape disfigured or hard to reach
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Healthy Premenopausal Period menstruating, pre-menopausal -  pregnant, lactating, post-menopausal, smoking, on birth control pills -
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 25.0-45.0,  Cervical Cancer women within the age range of 25-45 attending cervical cancer screening  previous history of HPV vaccine administration
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Cervix Uteri Dilation Subjects, females, 18 years of age or older. 2. Subjects undergoing any process that requires dilation (intrauterine procedures). 3. Subjects understanding the nature of the study and willing to sign informed consent form  Subjects younger than 18 years of age. 2. Subject with the following infectious diseases: HIV, HBV, HCV, Syphilis. 3. Subject has been treated with any cervix dilating agent within 2 months before the screening. 4. Known contraindications or hypersensitivity to the components of the investigational product. 5. The patient has a condition or a concurrent severe and/or uncontrolled medical disease which could compromise participation, compliance with, and/or completion with study procedures. 6. Subjects undergoing abortion <7 and >9 weeks of pregnancy. 7. Subjects unwilling to sign the informed consent form
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-95.0,  Uterine Cervical Neoplasms Patient with a diagnosis of cervical cancer  Non applicable
Patient description: The patient is a 37-year-old woman who came to the clinic for a routine Pap smear. The test revealed stage 1B of cervical cancer. The patient tested positive for HPV 16. She has three sexual partners and four children. She underwent tubal ligation. She smokes 30 packs/year and drinks alcohol frequently. She is otherwise healthy. She was offered a radical hysterectomy.

Clinical trial eligibility criteria: eligible ages (years): 18.0-999.0,  Human Immunodeficiency Virus (HIV) Human Papillomavirus (HPV) Currently enrolled in the Women's HIV Interagency Study (WIHS) study Able and willing to undergo anal cytology, anal molecular testing, and high resolution anoscopy with targeted anal biopsies  History of high grade anal intraepithelial neoplasia (AIN 2 or 3) History of active anal disease requiring surgery History of anal or cervical cancer